BIOMAT Database Logo BIOMAT Database Logo

Lipid abnormalities induced by novel antipsychotic drugs. 2001

K P Su, and W W Shen, and S Y Huang

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D015228 Hypertriglyceridemia A condition of elevated levels of TRIGLYCERIDES in the blood. Hypertriglyceridemias
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid

Related Publications

K P Su, and W W Shen, and S Y Huang
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
January 2005, Przeglad lekarski,
K P Su, and W W Shen, and S Y Huang
[Dementia induced by antipsychotic drugs].
January 2004, Nihon rinsho. Japanese journal of clinical medicine,
K P Su, and W W Shen, and S Y Huang
[Neurological syndromes induced by antipsychotic drugs].
January 2004, La Clinica terapeutica,
K P Su, and W W Shen, and S Y Huang
Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs.
January 2019, Frontiers in pharmacology,
K P Su, and W W Shen, and S Y Huang
Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs.
January 2005, International review of neurobiology,
K P Su, and W W Shen, and S Y Huang
The novel antipsychotic drugs.
September 2002, The Harvard mental health letter,
K P Su, and W W Shen, and S Y Huang
Novel versus conventional antipsychotic drugs.
January 1996, Pharmacotherapy,
K P Su, and W W Shen, and S Y Huang
Development of novel antipsychotic drugs.
March 2000, Brain research. Brain research reviews,
K P Su, and W W Shen, and S Y Huang
Use of novel antipsychotic drugs.
January 1996, Pharmacotherapy,
K P Su, and W W Shen, and S Y Huang
Direct visualization of phase separation induced by phenothiazine-type antipsychotic drugs in model lipid membranes.
February 2011, Molecular membrane biology,
Copied contents to your clipboard!